[go: up one dir, main page]

KR20170111057A - 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법 - Google Patents

면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법 Download PDF

Info

Publication number
KR20170111057A
KR20170111057A KR1020160035806A KR20160035806A KR20170111057A KR 20170111057 A KR20170111057 A KR 20170111057A KR 1020160035806 A KR1020160035806 A KR 1020160035806A KR 20160035806 A KR20160035806 A KR 20160035806A KR 20170111057 A KR20170111057 A KR 20170111057A
Authority
KR
South Korea
Prior art keywords
mesenchymal stem
cell culture
stem cell
disease
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020160035806A
Other languages
English (en)
Korean (ko)
Inventor
이성구
김미형
Original Assignee
(주)안트로젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)안트로젠 filed Critical (주)안트로젠
Priority to KR1020160035806A priority Critical patent/KR20170111057A/ko
Priority to PCT/KR2016/009112 priority patent/WO2017164467A1/fr
Publication of KR20170111057A publication Critical patent/KR20170111057A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0031—Serum-free culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020160035806A 2016-03-25 2016-03-25 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법 Ceased KR20170111057A (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020160035806A KR20170111057A (ko) 2016-03-25 2016-03-25 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법
PCT/KR2016/009112 WO2017164467A1 (fr) 2016-03-25 2016-08-18 Culture de cellules souches mésenchymateuses pour la prévention ou le traitement d'une maladie immunitaire ou d'une maladie inflammatoire et procédé de préparation associé

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160035806A KR20170111057A (ko) 2016-03-25 2016-03-25 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020180071300A Division KR20180072644A (ko) 2018-06-21 2018-06-21 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법

Publications (1)

Publication Number Publication Date
KR20170111057A true KR20170111057A (ko) 2017-10-12

Family

ID=59900602

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160035806A Ceased KR20170111057A (ko) 2016-03-25 2016-03-25 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법

Country Status (2)

Country Link
KR (1) KR20170111057A (fr)
WO (1) WO2017164467A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020004698A1 (fr) * 2018-06-27 2020-01-02 (주) 티아라줄기세포연구소 Procédé de préparation d'une composition de milieu de culture cellulaire, procédé de préparation d'un extrait de lysat de cellules souches (cellules souches enveloppées) en utilisant le procédé de préparation de la composition de milieu de culture cellulaire et procédé d'extraction triconditionnel d'ingrédient efficace pour les cellules souches, composition thérapeutique anti-arthrite l'utilisant, composition thérapeutique anti-inflammatoire l'utilisant, et composition thérapeutique de régénération de cellules
KR20200019367A (ko) * 2018-08-14 2020-02-24 주식회사 티스템 세포배양용 배지 조성물 제조방법, 세포배양용 배지 조성물 제조방법과 줄기세포 유효성분 3저 추출법을 이용한 줄기세포파쇄추출물(쉘드줄기세포) 제조방법, 이를 이용한 항관절염 치료용 조성물, 이를 이용한 항염증 치료용 조성물 및 세포재생 치료용 조성물
WO2020122498A1 (fr) * 2018-12-13 2020-06-18 에스씨엠생명과학 주식회사 Composition pharmaceutique pour le traitement de la pancréatite, comprenant des cellules souches clonales
KR20210069851A (ko) * 2019-12-04 2021-06-14 건국대학교 산학협력단 중간엽 줄기세포의 면역조절 활성 증진용 조성물

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800020722A1 (it) * 2018-12-21 2020-06-21 Assunta Borzacchiello Biomateriale e suo utilizzo nel trattamento di patologie polmonari
US10881693B2 (en) 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
US20220401492A1 (en) * 2019-11-18 2022-12-22 YJ Cerapeutics Inc. Composition for treating spinal cord injury, comprising stem cells treated with novel compound
KR20230035517A (ko) 2020-04-07 2023-03-14 컴반지오, 인크. 동결건조 중간엽 줄기세포 유래 세크레톰 및 이의 용도
CN114561344A (zh) * 2021-11-25 2022-05-31 中国人民解放军空军军医大学 可提高干细胞免疫调控能力的无血清培养基及制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101189655B1 (ko) * 2010-06-30 2012-10-11 성균관대학교산학협력단 줄기세포 배양액을 포함하는 폐질환 치료용 조성물
KR101639988B1 (ko) * 2011-05-11 2016-07-15 (주)안트로젠 고농도의 세포성장인자를 포함하는 중간엽 줄기세포 배양액의 제조방법 및 이로부터 얻어진 조성물
KR20150029280A (ko) * 2013-09-10 2015-03-18 (주)안트로젠 당뇨성 창상 치유를 위한 자가 및 동종의 지방 유래 중간엽 줄기세포 조성물
KR102191789B1 (ko) * 2014-07-01 2020-12-16 주식회사 스마트셀랩 저분자 화합물로 인한 인간 골수유래 중간엽 줄기세포 성장인자의 발현 제어 및 분비를 촉진하는 성장인자 대량 생산방법
WO2016029267A1 (fr) * 2014-08-27 2016-03-03 Prince Henry's Institute Of Medical Research Trading As The Hudson Institute Of Medical Research Procédé de culture de cellules souches mésenchymateuses

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020004698A1 (fr) * 2018-06-27 2020-01-02 (주) 티아라줄기세포연구소 Procédé de préparation d'une composition de milieu de culture cellulaire, procédé de préparation d'un extrait de lysat de cellules souches (cellules souches enveloppées) en utilisant le procédé de préparation de la composition de milieu de culture cellulaire et procédé d'extraction triconditionnel d'ingrédient efficace pour les cellules souches, composition thérapeutique anti-arthrite l'utilisant, composition thérapeutique anti-inflammatoire l'utilisant, et composition thérapeutique de régénération de cellules
KR20200001370A (ko) * 2018-06-27 2020-01-06 주식회사 티아라줄기세포연구소 지방줄기세포배양용 배지 조성물 제조방법, 지방줄기세포배양용 배지 조성물 제조방법과 줄기세포 유효성분 3저 추출법을 이용한 줄기세포파쇄추출물(쉘드줄기세포) 제조방법, 이를 이용한 항관절염 치료용 조성물, 이를 이용한 염증억제 효과를 갖는 조성물 및 세포재생 효과를 갖는 조성물
KR20200019367A (ko) * 2018-08-14 2020-02-24 주식회사 티스템 세포배양용 배지 조성물 제조방법, 세포배양용 배지 조성물 제조방법과 줄기세포 유효성분 3저 추출법을 이용한 줄기세포파쇄추출물(쉘드줄기세포) 제조방법, 이를 이용한 항관절염 치료용 조성물, 이를 이용한 항염증 치료용 조성물 및 세포재생 치료용 조성물
WO2020122498A1 (fr) * 2018-12-13 2020-06-18 에스씨엠생명과학 주식회사 Composition pharmaceutique pour le traitement de la pancréatite, comprenant des cellules souches clonales
KR20210069851A (ko) * 2019-12-04 2021-06-14 건국대학교 산학협력단 중간엽 줄기세포의 면역조절 활성 증진용 조성물

Also Published As

Publication number Publication date
WO2017164467A1 (fr) 2017-09-28

Similar Documents

Publication Publication Date Title
KR20170111057A (ko) 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법
KR101639988B1 (ko) 고농도의 세포성장인자를 포함하는 중간엽 줄기세포 배양액의 제조방법 및 이로부터 얻어진 조성물
Bieback et al. Clinical protocols for the isolation and expansion of mesenchymal stromal cells
Sharma et al. Translational products of adipose tissue-derived mesenchymal stem cells: Bench to bedside applications
CN105154395B (zh) 一种增强MSCs免疫调节功能的临床级别细胞制备方法
Riis et al. Critical steps in the isolation and expansion of adipose-derived stem cells for translational therapy
KR20180111674A (ko) 중간엽줄기세포 유래 고순도, 고농도 엑소좀을 포함하는 배양액 및 이의 제조방법
CN102367435B (zh) 人富血小板血浆的制备及在人间充质干细胞分离培养中的应用
CN111454893B (zh) 一种无血清、无异源成分的间充质干细胞培养基及其应用
CN101802177A (zh) 从人或动物胚胎提取间质性干细胞及提取其分泌物的方法
JP2020191861A (ja) 臍帯間葉系幹細胞ＭＳＣｓ及びその培養法と応用
KR20180072644A (ko) 면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법
JP2007520462A (ja) ヒト臍帯血由来多能性細胞の疾患の処置のための使用方法
Zhang et al. Adipose tissue-derived pericytes for cartilage tissue engineering
KR20150029280A (ko) 당뇨성 창상 치유를 위한 자가 및 동종의 지방 유래 중간엽 줄기세포 조성물
JP7154586B2 (ja) 幹細胞の効能改善のための組成物及び方法
Tevlin et al. A novel method of human adipose-derived stem cell isolation with resultant increased cell yield
KR20210145705A (ko) 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법
Şovrea et al. State of the art in human adipose stem cells and their role in therapy
Fink et al. Isolation and expansion of adipose-derived stem cells for tissue engineering
KR102588400B1 (ko) 면역 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법
Gottipamula et al. Mesenchymal Stromal Cells: Basics, Classification, and Clinical Applications.
KR20190004253A (ko) 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법
CN106191127A (zh) 干细胞生物活性组合物及其制备方法与应用
Stolzing et al. Effect of age and diabetes on the response of mesenchymal progenitor cells to fibrin matrices

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20160325

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20170808

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20160325

Comment text: Patent Application

A302 Request for accelerated examination
PA0302 Request for accelerated examination

Patent event date: 20170811

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

Patent event date: 20160325

Patent event code: PA03021R01I

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170829

Patent event code: PE09021S01D

PG1501 Laying open of application
AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180129

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170829

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20180129

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20171030

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20180423

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20180322

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20180129

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20171030

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20170829

PA0107 Divisional application

Comment text: Divisional Application of Patent

Patent event date: 20180621

Patent event code: PA01071R01D